Who We Are

Who We Are

Shanghai Shen Lian Biomedical Corporation

Shanghai Shen Lian Biomedical Corporation, established in June 2001 with a registered capital of 410.64 million RMB, is a high-tech enterprise specializing in the research, development,production, and sales of veterinary biological products. The headqarter is based in Shanghai.

In October 2019, the company was successfully listed on the Shanghai Stock Exchange's STAR Market with the stock code 688098.

The company's main business covers the research, production, and sales of veterinary
preventive biological products and veterinary diagnostic products. It has two GMP production facilities in Shanghai and Lanzhou and is a designated enterprise for foot-and-mouth disease (FMD) vaccines by the Chinese Ministry of Agriculture and Rural Affairs. The company focuses on diseases that threaten the safety of the breeding industry and have a high demand for vaccines.The products on the market include vaccines for swine FMD and porcine circovirus (PCV), and diagnostic reagents for FMD and African swine fever (ASF). It is also developing other animal vaccines and veterinary diagnostic products.

Company Culture

Vision

To build a world-class high-tech biotech company.

Mission

Pioneer in life sciences, create great health endeavors for humanity.

Values

Build a platform for employees, contribute to society.

Concept

Innovation leads development, quality builds brand, integrity serves customers, talent builds the future together.

History

History
History
History
2025
  • Laying out human pharmaceuticals, making external investments in Shi Zhi Yuan Company.
  • The genetically engineered subunit vaccine for swine fever (CHO-133D) has obtained a product approval number.
2024
  • Inactivated vaccine for bovine lumpy skin disease, pseudorabies virus gB competitive ELISA antibody detection kit for pigs.
  • ELISA antibody detection kit for Seneca virus type A in pigs is on the market for sale.
  • The genetically engineered subunit vaccine for swine fever has obtained a Class III new veterinary drug certificate.
  • Construction of the mRNA production workshop has started.
2023
  • Building a veterinary mRNA technology platform.
  • The inactivated vaccine for bovine lumpy skin disease has passed the emergency evaluation of the Ministry of Agriculture and Rural Affairs.
  • The FMD vaccine (for cattle and sheep) has obtained an approval number.
  • The diagnostic reagent for FMD virus in cattle and sheep has obtained a product approval number.
  • The diagnostic reagent for Seneca virus type A in pigs has obtained a Class II new veterinary drug certificate
2022
  • The "one body, two wings" product strategy has been formed.
  • The cell suspension culture virus subunit vaccine production line has passed GMP acceptance.
  • Diagnostic products have been launched.
  • The porcine circovirus vaccine has obtained a product approval number.
2021
  • The subunit vaccine for Porcine circovirus type 2 has obtained a new veterinary drug registration certificate.
  • The bivalent synthetic peptide vaccine for Bovine FMD types O and A has obtained a new veterinary drug certificate.
  • The FMD inactivated vaccine production line using cell suspension culture has passed the new version of veterinary GMP acceptance. The FMD synthetic peptide vaccine production line has passed the new version of veterinary GMP acceptance.
  • Shenlian Biomedical's molecular biology diagnostic products production line has passed GMP acceptance.
  • Shenlian Biomedical's products from its first public offering and fundraising projects have officially started production.
2020
  • The FMD(suspension) production line has passed the biosafety level 3 protection acceptance for veterinary vaccines.
  • Shenlian Biomedical has been honored with the Global Scientific and Technological Innovation Advancement Award.
  • The veterinary product "African Swine Fever Virus Fluorescent PCR Nucleic Acid Detection Kit" has been approved for production by the Ministry of Agriculture and Rural Affairs.
2019
  • The first company in the industry to be listed on the STAR Market, stock code 688098.
  • Shenlian Biomedical's immunology diagnostic products production line passed GMP inspection.
  • The avian influenza virus H7 subtype fluorescent RT-PCR detection kit obtained a new veterinary drug certificate.
2018
  • The bivalent synthetic peptide vaccine for swine FMD types O and A has obtained a new veterinary drug certificate.
2017
  • The bivalent inactivated vaccine for swine FMD types O and A, developed by Shenlian Biomedical, has obtained a Class I new veterinary drug certificate.
2016
  • Awarded the Second Prize of National Science and Technology Progress Award.
2015
  • Shenlian Biomedical underwent shareholding system reform.
  • Shenlian Biomedical's trademark was awarded "Famous Trademark of Shanghai".
2014
  • Shanghai Shen Lian Biomedical Corporation Lanzhou Branch was established.
  • The swine FMD type O synthetic peptide vaccine (triple-component) obtained a new veterinary drug certificate.
2009
  • The swine FMD type O synthetic peptide vaccine (dual-component) product was launched.
2007
  • The first domestic production line for FMD synthetic peptide vaccine passed GMP inspection.
  • The first domestic FMD synthetic peptide vaccine product was launched.
2004
  • The synthetic peptide vaccine for swine FMD type O has obtained a Class I new veterinary drug certificate, marking the first synthetic peptide vaccine for FMD in China.
2001
  • Shanghai Shen Lian Biomedical Corporation was established.
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2009
2007
2004
2001

Certificate of Honor

Gold Award of China (Shanghai) International Exhibition of Inventions

Gold Award National Science and Technology Progress Award

Global Science and Technology Innovation Advanced Award

Gold Award for Outstanding Invention at the 33rd Shanghai Outstanding Invention Selection Competition

High and New Technology Enterprise

Contract Credit Rating Certificate

Shanghai May 1st Labor Award Certificate

Shanghai Workers’ Innovation Studio

Shanghai Enterprise Technology Center

Pilot Enterprise for Patent Work in Shanghai

Minhang District Technology Little Giant Cultivation Enterprise

Specialized, Sophisticated, Unique, and Innovative Enterprise

Shanghai Brand Cultivation Demonstration Enterprise

Shanghai Top 100 High-tech Achievement Transformation Projects, Top 10 Independent Innovation

Shennong China Agricultural Science and Technology Award

China Academy of Agricultural Sciences Science and Technology Achievement Award

Annual Influential FMD Vaccine

Annual Emerging Company Leader

National Agriculture, Animal Husbandry, and Fishery Harvest Award

Most IR (Investor Relations) Value Company of the Year

Silver Award of the 9th International Invention Exhibition
MSG